| [1] |
Hai An HP, Diem HT, Cuong NT. Parvovirus B19 associated anemia in kidney transplant recipients: a single-center experience [J]. Transplant Proc, 2019, 51(8): 2693-2696.
|
| [2] |
Porignaux R, Vuiblet V, Barbe C, et al. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation [J]. J Med Virol, 2013, 85(6): 1115-1121.
|
| [3] |
Ki CS, Kim IS, Kim JW, et al. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients [J]. Clin Transplant, 2005, 19(6): 751-755.
|
| [4] |
Prasad N, Novak JE, Patel MR. Kidney diseases associated with parvovirus B19, Hanta, Ebola, and Dengue virus infection: a brief review [J]. Adv Chronic Kidney Dis, 2019, 26(3): 207-219.
|
| [5] |
Ishikawa A, Yoto Y, Asakura H, et al. Quantitative analysis of human parvovirus B19 DNA in maternal and fetal serum, and amniotic fluid during an early stage of pregnancy [J]. J Med Virol, 2015, 87(4): 683-685.
|
| [6] |
Leisi R, Von Nordheim M, Ros C, et al. The VP1u receptor restricts parvovirus B19 uptake to permissive erythroid cells [J]. Viruses, 2016, 8(10): 265.
|
| [7] |
高佩娟，石运莹，普文申，等. 六例肾移植术后人细小病毒B19感染的临床特点和疗效分析[J]. 华西医学，2019, 34(7): 769-776.
|
| [8] |
Baek CH, Kim H, Yang WS, et al. Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients [J]. Transpl Infect Dis, 2017, 19(5): Epub ahead of print.
|
| [9] |
Gallinella G. The clinical use of parvovirus B19 assays: recent advances [J]. Expert Rev Mol Diagn, 2018, 18(9): 821-832.
|
| [10] |
Pabisiak K, Stepniewska J, Ciechanowski K. Pure red cell aplasia after kidney transplantation: parvovirus B19 culprit or coincidence [J]. Ann Transplant, 2019, 5(24): 123-131.
|
| [11] |
Ahmed W, Dogar RUH, Acharya S. Parvovirus B19: a rare cause of post-renal transplant anemia [J]. J Coll Physicians Surg Pak, 2017, 27(12): 785-187.
|
| [12] |
Cubel Garcia RC, Pereira RF, Azevedo KM, et al. Molecular diversity of human parvovirus B19 during two outbreaks of erythema infectiosum in Brazil [J]. Braz J Infect Dis, 2017, 21(1): 102-106.
|
| [13] |
Woolf AD, Campion GV, Chishick A, et al. Clinical manifestations of human parvovirus B19 in adults [J]. Arch Intern Med, 1989, 149(5): 1153-1156.
|
| [14] |
Bonvicini F, Bua G, Gallinella G. Parvovirus B19 infection in pregnancy-awareness and opportunities [J]. Curr Opin Virol, 2017, 27: 8-14.
|
| [15] |
Eid AJ, Brown RA, Patel R, et al. Parvovirus B19 infection after transplantation: a review of 98 cases [J]. Clin Infect Dis, 2006, 43(1): 40-48.
|
| [16] |
Nair V, Jandovitz N, Jhaveri KD, et al. Treatment of parvovirus B19 viremia to facilitate kidney transplantation in a patient with collapsing glomerulopathy [J]. Clin Nephrol Case Stud, 2020, 8: 41-45.
|
| [17] |
Akeda S, Takaeda C, Takazakura E, et al. Renal involvement induced by human parvovirus B19 infection [J]. Nephron, 2001, 89(3): 280-285.
|
| [18] |
Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, et al. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process [J]. Virus Res, 2014, 190: 8-16.
|
| [19] |
Razonable RR. Not the usual viral suspects: parvovirus B19, West Nile virus, and human T-cell lymphotrophic virus infections after kidney transplantation [J]. Semin Nephrol, 2016, 36(5): 428-434.
|
| [20] |
Metzgar D, Lovari R, Ray K, et al. Analytical characterization of an assay designed to detect and identify diverse agents of disseminated viral infection [J]. Clin Viro, 2014, 59(3): 177-183.
|
| [21] |
Bodewes R, Kerkhof J, Cremer J, et al. Oral fluid: non-invasive alternative for parvovirus B19 diagnosis [J]. J Clin Virol, 2019, 117: 5-10.
|
| [22] |
Plentz A, Würdinger M, Kudlich M, et al. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia [J]. J Clin Virol, 2013, 58(2): 443-448.
|
| [23] |
AST Infectious Diseases Community of Practice, Eid AJ, Chen SF. Human parvovirus B19 in solid organ transplantation [J]. Am J Transplant, 2013, 13(Suppl 4): 201-205.
|
| [24] |
Mende M, Sockel K. Parvovirus B19 infection [J]. N Engl J Med, 2018, 379(24): 2361.
|
| [25] |
Bonvicini F, Bua G, Manaresi E, et al. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells [J]. Virus Res, 2016, 220: 47-51.
|
| [26] |
Manaresi E, Gallinella G. Advances in the development of antiviral strategies against parvovirus B19 [J]. Viruses, 2019, 11(7): 659.
|
| [27] |
常万兴，赵亚昆，王海平，等. 肾移植术后人细小病毒B19感染的诊治体会[J]. 临床外科杂志，2020, 28(9): 882-884.
|
| [28] |
Šutová I, Chovancová Z, Litzman J. Adverse effects of immunoglobulin therapy [J]. Vnitr Lek, 2019, 65(2): 131-132.
|
| [29] |
Tiong M, Casan J, McLean C, et al. A traumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant [J]. Transpl Infect Dis, 2019, 21(2): e13045.
|
| [30] |
Rosado-Canto R, Carrillo-Pérez DL, Jiménez JV, et al. Treatment strategies and outcom of parvovirus B19 infection in kidney transplant recipients: a case series and literature review of 128 patients [J]. Rev Invest Clin, 2019, 71(4): 265-274.
|
| [31] |
Rivas-Delgado A, Matutes E, Rozman M. Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection [J]. Br J Haematol, 2016, 172(4): 495.
|
| [32] |
Chandramouli S, Medina-Selby A, Coit D, et al. Generation of a parvovirus B19 vaccine candidate [J]. Vaccine, 2013, 31(37): 3872-3878.
|
| [33] |
Penkert RR, Young NS, Surman SL, et al. Saccharomyces cerevisiae-derived virus-like particle parvovirus B19 vaccine elicits binding and neutralizing antibodies in a mouse model for sickle cell disease [J]. Vaccine, 2017, 35(29): 3615-3620.
|
| [34] |
Romero Starke K, Kofahl M, Freiberg A, et al. Are daycare workers at a higher risk of parvovirus B19 infection? A systematic review and meta-analysis [J]. Int J Environ Res Public Health, 2019, 16(8): 1392.
|